PD consultancy for AbbVie, AstraZeneca, bluebird bio, Gilead, Janssen, Miltenyi, Novartis, Riemser, Roche; speakers bureau for AbbVie, AstraZeneca, Gilead, Novartis, Riemser, Roche; research support from Riemser; UH honoraria from Novartis, Gilead, BMS, Miltenyi, Roche; MS research support Amgen, BMS, Gilead, Miltenyi, MorphoSys, Novartis, Roche, Seagen, Advisory Board Amgen, BMS, Gilead, Janssen, Novartis, Pfizer, Seagen, Speaker’s Bureau Amgen, BMS, Gilead, Novartis, Pfizer, Takeda; BvT advisor or consultant for BMS/Celgene, Incyte, Miltenyi, Novartis, Pentixafarm, Amgen, Pfizer, Takeda, MSD, Gilead Kite, honoraria from AstraZeneca, Novartis, Roche, Takeda, and MSD, research funding from Novartis, MSD, Takeda, travel support from AbbVie, AstraZeneca, Kite-Gilead, MSD, Takeda, Novartis; FA honoraria from Novartis, Gilead, BMS, Janssen, Takeda, Therakos/Mallinckrodt, research funding from Therakos/Mallinckrodt; GW honoraria Gilead, Novartis, Takeda, Clinigen, Amgen; OP honoraria or travel support from Astellas, Gilead, Jazz, MSD, Neovii Biotech, Novartis, Pfizer and Therakos, research support from Gilead, Incyte, Jazz, Neovii Biotech and Takeda, advisory boards of Jazz, Gilead, MSD, Omeros, Priothera, Shionogi and SOBI; US advisory board Novartis; CK Advisory boards: Abbvie, Amgen, BMS, EusaPharm, GSK, Janssen, Kite/Gilead, Medigene, Novartis, Roche, Sanofi, Takeda, Pfizer, Incyte; MvB honoraria and travel funds Gilead, Novartis, Janssen, Takeda, Daiichi Sankyō; MSt honoraria Kite/Gilead, Jazz, MSD, Novartis, Pfizer, BMS/Celgene; CDB received honoraria and travel funds from BMS, Amgen, Novartis, Jazz, Gilead, Janssen; VV honoraria and travel funds for Gilead, honoraria and consultancies for Novartis, Gilead, BMS/Celgene; DM consultancies for AbbVie, Roche, BMS, Hexal, Novartis, MSD, Celgene, Janssen-Cilag, Pfizer, Astra-Zeneca, and Jazz Pharma; DW honoraria from Behring, BMS, Gilead, Novartis, Takeda; research support from Novartis; ST honoraria and travel funds Abbvie, BMS/Celgene, EUSA Pharma, Janssen, Gilead, Medigene, Novartis, Pfizer; Research funding BMS/Celgene, Gilead; NK honoraria Kite/Gilead, Jazz, MSD, Neovii Biotech, Novartis, Riemser, Pfizer, BMS Research support from Neovii, Riemser, Novartis, BMS; WB honoraria and travel funds Gilead, Novartis, Miltenyi and Janssen, Research grants Miltenyi. BG, RM, RS, MT and EW declare no competing interests.